Article

Transcriptome analysis revealed FABP5 as a serum marker of metabolic associated fatty liver disease

2023-12-06

Abstract excerpt

<h4>Objective: </h4> The pathogenesis of metabolic (dysfunction) associated fatty liver disease (MAFLD) is very complex, which has not been fully revealed as so far. In our study, the third-generation ONT (Oxford nanopore technologies) sequencing platform was used to explore the key differentially expressed genes involved in the pathogenesis of MAFLD. <h4>Methods: </h4>: In the present study, we firstly fed male C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5ca0fd7b-63df-5706-9673-38db4f86f095
DOI: 10.21203/rs.3.rs-3691351/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptome analysis revealed FABP5 as a serum marker of metabolic associated fatty liver diseaseDOI 10.21203/rs.3.rs-3691351/v1Read

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factorsSemantic proximity Read

A novel gene signature to diagnose MASLD in metabolically unhealthy obese individualsSemantic proximity Read

Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read

Advances in genetic variation in metabolism-related fatty liver diseaseSemantic proximity Read

Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLDSemantic proximity Read

Genetic variants associated with metabolic dysfunction-associated fatty liver diseases in a Korean populationSemantic proximity Read

Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance Semantic proximity Read

Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome AnalysisSemantic proximity Read

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.Semantic proximity Read

The contribution of genetics and epigenetics to MAFLD susceptibility.Semantic proximity Read

Based on bioinformatics analysis of nonalcoholic fatty liver disease associated with metabolic biomarkersSemantic proximity Read